Ep 13: PathAI CEO Dr. Andy Beck on the Future of AI in Medical Diagnosis

Jacob sits down with PathAI Ceo Dr. Andy Beck to discuss the state of AI adoption in diagnosis, why Path acquired their own lab, pathologists' jobs in the future and nailing GTM to reach a ~$1B valuation.

00:00 intro
01:01 pathology and AI
13:30 nailing go-to-market strategy
19:47 how pathology labs can go digital
25:36 regulatory frameworks and roadblocks
33:05 do improvements in foundation models impact PathAI?
36:26 standardizing diagnosis
40:05 how will the job of a pathologist change going forward?
42:35 NASH
47:30 working in Daphne Koller’s lab

With your co-hosts:
@jasoncwarner - Former CTO GitHub, VP Eng Heroku & Canonical
@ericabrescia - Former COO Github, Founder Bitnami (acq’d by VMWare)
@patrickachase - Partner at Redpoint, Former ML Engineer LinkedIn
@jacobeffron - Partner at Redpoint, Former PM Flatiron Health
@jordan_segall - Partner at Redpoint

Jacob is an AI investor at Redpoint Ventures. He's led Redpoint's investments in companies like Abridge, Physical Intelligence & Legora. Follow Jacob on Twitter (@jacobeffron).

On Unsupervised Learning we probe the sharpest minds in AI in search for the truth about what's real today, what will be real in the future and what it all means for businesses and the world. If you're a builder, researcher or investor navigating the AI world, this podcast will help you deconstruct and understand the most important breakthroughs and see a clearer picture of reality. Subscribe to this show to stay up to date on our latest episodes.